| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.073 | 0.1 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.082 | 0.1 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.044 | 0.1 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.049 | 0.1 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | -0.24 | 0.1 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |